School of Medicine
Showing 1-7 of 7 Results
Professor of Health Research and Policy and by courtesy, of Economics
Current Research and Scholarly Interests Dr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
M. Kate Bundorf
Associate Professor of Health Research and Policy and, by courtesy, in Political Economics at the Graduate School of Business
Current Research and Scholarly Interests Her research focuses on health insurance markets including the determinants and effects of individual and purchaser choices, the effects of regulation in insurance markets, the interaction of public and private systems of health insurance, and incentives for insurers to improve health care quality.
Senior Lecturer in Health Research and Policy
Current Research and Scholarly Interests My research interests involve doctor-patient relationship and communication strategies as they pertain to (1) the development and instruction of medical Spanish curriculum, (2) satisfaction in health care delivery with emphasis on cross cultural competency issues, and (3) the effectiveness of interpretive systems in health care settings.
Monica Eneriz Wiemer
Clinical Instructor, Pediatrics - General Pediatrics
Current Research and Scholarly Interests I am interested in improving health and developmental outcomes for children born to immigrant families. Specifically, I am investigating the relationship of parental limited English proficiency to child health and developmental outcomes, particularly among children with special health care needs (such as children born with very low birth weight).
Mark Hlatky, MD
Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.